Paracetamol and Copaxone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paracetamol (acetaminophen) and Copaxone (glatiramer acetate). Common drug interactions include asthenia among females and chest pain among males.

The phase IV clinical study analyzes what interactions people have when they take Paracetamol and Copaxone. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Paracetamol?

Paracetamol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 115,650 Paracetamol users. Check the latest studies of Paracetamol.

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

On Jul, 14, 2026

65 people who take Paracetamol and Copaxone together, and have interactions are studied.

Paracetamol and Copaxone drug interactions.

What are the common drug interactions of Paracetamol and Copaxone, by gender? *:

female:

Asthenia (weakness)
B-cell type acute leukaemia (cancer of the white blood cells)
Balance disorder
Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
Bladder disorder
Blood calcium increased
Blood glucose increased
Blood thyroid stimulating hormone increased
Burns third degree
Cardiac failure congestive

male:

Chest pain
Chills (felling of cold)
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Death
Depression
Diarrhoea
Gastrointestinal inflammation (inflammation of stomach and intestine)
Haemorrhagic transformation stroke (haemorrhages develop inside areas of ischemia)
Hallucination, visual (seeing things that aren't there)
Hyperhidrosis (abnormally increased sweating)

What are the common drug interactions of Paracetamol and Copaxone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Death
Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)

10-19:

n/a

20-29:

Chest pain
Dyspnoea (difficult or laboured respiration)
Chest discomfort
Cough
Drug intolerance (drug sensitivity)
Gait disturbance
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Hyperthyroidism (over activity of the thyroid gland)
Hypoaesthesia (reduced sense of touch or sensation)
Hypokinesia (decreased bodily movement)

30-39:

Panic reaction
Peripheral swelling
Pleural effusion (water on the lungs)
Pruritus (severe itching of the skin)
Pulmonary oedema (fluid accumulation in the lungs)
Renal colic (renal pain)
Respiratory failure (inadequate gas exchange by the respiratory system)
Somnolence (a state of near-sleep, a strong desire for sleep)
Stridor
Throat irritation

40-49:

Confusional state
Pyelonephritis (inflammation of kidney caused by bacteria)
Abnormal behaviour
Aggression
Anaphylactic reaction (serious allergic reaction)
Asthenia (weakness)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Depression
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Fatigue (feeling of tiredness)

50-59:

Diarrhoea
Hepatic steatosis (fatty liver disease)
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Nausea (feeling of having an urge to vomit)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Blood calcium increased
Blood glucose increased
Pharyngitis (inflammation of the pharynx, causing a sore throat)
Uveitis (inflammation of the uvea)
Vulvovaginal mycotic infection (vulvovaginal fungal infection)

60+:

Embolia cutis medicamentosa (livedoid dermatitis occurs immediately after an intramuscular injection)
Fall
Drug effect decreased
Extranodal marginal zone b-cell lymphoma (malt type) (cancer originating from b cells in the marginal zone of the malt)
Gait disturbance
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Haemorrhagic diathesis (bleeding tendency)
Hallucination, auditory (perceiving sounds without auditory stimulus)
Hearing impaired
Hypercalcaemia (elevated calcium (ca+) level in the blood)

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 15 people, 23.08%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 7.69%
Gait Disturbance: 5 people, 7.69%
High Blood Pressure: 4 people, 6.15%
Depression: 4 people, 6.15%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Paracetamol and Copaxone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously